Bioinformatics Analysis Identifies EPAS1 as a Novel Prognostic Marker Correlated with Immune Infiltration in Acute Myeloid Leukemia

<div>Construction and validation of the nomogram for AML patients. (a) Nomogram for predicting the probability of 1-, 3-, and 5-year over survival (OS) for AML patients. (b) Calibration plot of the nomogram for predicting the probability at 1, 2, and 3 years.</div>

Disease Markers

fig9

Figure 9

Figure 9: Bioinformatics Analysis Identifies EPAS1 as a Novel Prognostic Marker Correlated with Immune Infiltration in Acute Myeloid Leukemia 